Keyphrases
Adverse Cardiovascular Events
13%
All-cause Mortality
29%
Aortic Stenosis
11%
Atrial Fibrillation
27%
Beta-blockers
18%
Body Mass Index
12%
Cardiovascular Disease
11%
Cardiovascular Mortality
18%
Cardiovascular Risk
15%
Clopidogrel
8%
Comorbidity
28%
Confidence Interval
43%
Coronary Angiography
12%
Coronary Artery Disease
17%
COVID-19
9%
Denmark
31%
Diabetes
18%
Dilated Cardiomyopathy
9%
First-degree Relatives
12%
Framingham Heart Study
16%
Genetic Risk Score
9%
Hazard Ratio
31%
Heart Failure
77%
Heart Failure Hospitalization
10%
Heart Failure Patients
27%
Hypertension
16%
Incidence Rate
25%
Ischemic Heart Disease
9%
Ischemic Stroke
17%
Lockdown
8%
Major Adverse Cardiovascular Events
18%
Metformin
12%
Mortality Risk
21%
Multivariable
9%
Myocardial Infarction
50%
National Cohort Study
61%
Nationwide Registry
8%
New Onset
9%
New-onset Heart Failure
12%
Noncardiac Surgery
21%
Odds Ratio
18%
Out-of-hospital Cardiac Arrest
11%
Patients with Heart Failure
25%
Pharmacotherapy
11%
Register Study
9%
Risk Factors
15%
Systemic Sclerosis
9%
Temporal Trends
14%
Trends in Incidence
11%
Type 2 Diabetes Mellitus (T2DM)
13%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
10%
Adverse Outcome
7%
All Cause Mortality
26%
Anemia
5%
Aortic Stenosis
5%
Aortic Valve Stenosis
8%
Atrial Fibrillation
20%
Beta Adrenergic Receptor Blocking Agent
10%
Brain Ischemia
17%
Cardiovascular Agent
7%
Cardiovascular Disease
35%
Cardiovascular Mortality
6%
Cardiovascular Risk
7%
Clopidogrel
7%
Cohort Study
58%
Combination Therapy
10%
Comorbidity
25%
Congestive Cardiomyopathy
6%
Coronary Artery Disease
5%
Coronavirinae
9%
Diabetes Mellitus
10%
Disease
17%
Genetic Risk
5%
Heart Failure
100%
Heart Infarction
53%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
8%
Ischemic Heart Disease
17%
Loop Diuretic Agent
5%
Malignant Neoplasm
8%
Metabolic Disorder
7%
Metformin
12%
Mortality Rate
7%
New-Onset Atrial Fibrillation
5%
Non Insulin Dependent Diabetes Mellitus
19%
Obesity
15%
Out of Hospital Cardiac Arrest
9%
Pharmacotherapy
6%
Prevalence
17%
Renin-Angiotensin System Inhibitor
6%
Sulfonylurea
7%
Thromboembolism
7%
Warfarin
7%
Medicine and Dentistry
Adverse Event
7%
Adverse Outcome
5%
All Cause Mortality
11%
Aortic Stenosis
8%
Aortic Valve Stenosis
7%
Apoplexy
21%
Atrial Fibrillation
22%
Body Mass Index
7%
Brain Ischemia
11%
Cardiovascular Disease
22%
Cardiovascular Risk
5%
Cardiovascular System
35%
Child
6%
Cohort Analysis
27%
Cohort Effect
7%
Coronary Angiography
11%
Coronary Artery Disease
11%
COVID-19
14%
Diabetes
19%
Diabetes Mellitus
8%
Dilated Cardiomyopathy
7%
Disease
5%
Genetic Risk
9%
Glycon
9%
Hazard Ratio
19%
Heart Failure
69%
Heart Left Ventricle Ejection Fraction
7%
Ischemic Heart Disease
9%
Logistic Regression Analysis
5%
Malignant Neoplasm
9%
Maturity Onset Diabetes of the Young
9%
Meta-Analysis
7%
Mortality Rate
8%
Myocardial Infarction
10%
Noncardiac Surgery
16%
Odds Ratio
8%
Prevalence
12%
Proportional Hazards Model
6%
Systemic Scleroderma
9%
